The Paragraph IV process is the primary battleground for pharmaceutical patent disputes in the U.S
POR PORin
GLP-1 is naturally produced by the gastrointestinal system to increase insulin production, lower glucagon secretion, target areas in the brain that regulate appetite and slow intestinal motility leading to feeling of fullness
As healthcare professionals, our priority is your overall health
Understanding GLP-1 Medications: GLP-1 medications, or glucagon-like peptide-1 receptor agonists, represent a class of injectable drugs originally developed to manage type 2 diabetes and obesity
Traditionally, patients seeking a GLP-1 undergo a evaluation by a physician to determine whether they meet medical criteria typically a body mass index of 30 or higher, or certain obesity-related conditions and after discussing nutrition, exercise, potential side effects, and the likelihood that treatment may need to be lifelong